The global Urinalysis Market is projected to reach USD 8.52 billion by 2032, growing at a CAGR of 8.70%. Factors driving growth include increased preventive health screening, rising chronic illnesses, and advancements in diagnostic technologies. The U.S. market is set to reach USD 2.60 billion by 2032. Key drivers include rising health consciousness, chronic conditions, and technological innovations, with the U.S. market leading through 2032. The Consumables segment holds the largest market share in the Urinalysis Market due to high demand for test strips, reagents, and disposables. The Biochemical Urinalysis segment dominated the market in 2023, indicating various health conditions. The Disease Screening segment held the largest market share in 2023, driven by increasing chronic diseases globally. North America currently dominates the Urinalysis Market, with Asia-Pacific expected to register the fastest growth due to increasing healthcare infrastructure and rising chronic diseases. Major players in the market include Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, and more. The market is segmented by product type, test, application, and end user. The Urinalysis Market Report provides insights on market size, growth projections, key players, and regional analysis.

Read more at GlobeNewswire: Urinalysis Market to Surpass USD 8.52 Billion by 2032,